Follow the わかもと製薬株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €9.2bn. The latest transaction was disclosed on 27 August 2026 (Holding update). Among the most active insiders: Asset Value Investors Limited. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Wakamoto Pharmaceutical Co., Ltd. 是一家从事药品生产的日本公司。该公司在XTKS市场上市。